logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xiangcheng Li

Nanjing Medical University
H指数:32
被引数:4,030

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study

辅助仑伐替尼联合经动脉化疗栓塞治疗术后复发风险高的肝细胞癌患者：一项多中心前瞻性队列研究

Hepatobiliary & Pancreatic Diseases International
IF4.4
2025-03-260
PRE
Jin-Hong Chen; Lu Lu; Xiao-Yun Zhang; Bang-De Xiang; Xiao Xu; Xiang-Cheng Li; Zhi-Yong Huang; Tian-Fu Wen; Liu-Ping Luo; Jing Huang; Jian-Hong Zhong; Zhi-Kun Liu; Chang-Xian Li; Xin Long; Wen-Wei Zhu; Xin Yang; Chao-Qun Wang; Hu-Liang Jia; Ju-Bo Zhang; Yong-Yi Zeng; Cai-De Lu; Lun-Xiu Qin
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with FGF/FGFR genomic alterations: final results from FIGHT-201

Pemigatinib治疗转移性或手术不可切除的尿路上皮癌伴FGF/FGFR基因组改变: 来自FIGHT-201的最终结果

ANNALS OF ONCOLOGY
IF65.4
2024-02-018
OAAI
Necchi, A.; Pouessel, D.; Leibowitz, R.; Gupta, S.; Flechon, A.; Garcia-Donas, J.; Bilen, M. A.; Debruyne, P. R.; Milowsky, M. I.; Friedlander, T.; Maio, M.; Gilmartin, A.; Li, X.; Veronese, M. L.; Loriot, Y.

研究方向

暂未获取到该数据
张耀东 封面图
张耀东
H 指数:0论文数:1被引数:0
C
Changxian Li
H 指数:18论文数:137被引数:1,268
W
Wangjie Jiang
H 指数:15论文数:56被引数:800
X
Xuehao Wang
H 指数:63论文数:401被引数:1.3万
J
Jifei Wang
H 指数:18论文数:63被引数:749
X
Xuehao Wang
H 指数:16论文数:50被引数:1,769
G
Gu‐Wei Ji
H 指数:15论文数:55被引数:1,554
Y
Yananlan Chen
H 指数:8论文数:28被引数:177
R
Ruixiang Chen
H 指数:19论文数:107被引数:1,233
Y
Yirui Wang
H 指数:0论文数:10被引数:0